Search results

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

A group from Monash university has sought to make a new innovative nano-porous sieve material which has the potential to be produced on a global scale and is effective for a much longer time.

The final report on the safety of Building 23 by the independent expert review team has been completed.

Launch of the second phase of construction of the underground laboratory to detect dark matter.

Nuclear power is used as a reliable and clean energy solution in most OECD countries and many other parts of the world. Although it is banned in Australia, a number of government reviews are looking at current prohibitions on nuclear power.

Nuclear security experts and officials from Australia’s nuclear agencies have convened at the International Atomic Energy Agency’s (IAEA) headquarters in Vienna, Austria last week for the International Conference on Nuclear Security (ICONS).

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

Study shows for the first time that vegetation in the Windmill Islands, East Antarctica is changing rapidly in response to a drying climate.